Advanced search
Publication Cover
Journal of Receptors and Signal Transduction Volume 29, 2009 - Issue 1
Submit an article Journal homepage
380
Views
24
CrossRef citations to date
0
Altmetric
Review Article

Receptor-mediated tumor targeting with radiopeptides

Part 1. General principles and methods

Alex N. EberleLaboratory of Endocrinology, Department of Biomedicine, University Hospital and University Children’s Hospital, Basel, SwitzerlandCorrespondence[email protected]
&
Gabriele MildLaboratory of Endocrinology, Department of Biomedicine, University Hospital and University Children’s Hospital, Basel, Switzerland
Pages 1-37 | Received 30 Dec 2008, Accepted 04 Jan 2009, Published online: 01 Feb 2009

Citations (24)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Nagarani Thotakura, Poonam Parashar & Kaisar Raza. (2021) Assessing the pharmacokinetics and toxicology of polymeric micelle conjugated therapeutics. Expert Opinion on Drug Metabolism & Toxicology 17:3, pages 323-332.
Read now

Articles from other publishers (23)

Palmira Alessia Cavallaro, Marzia De Santo, Emilia Lucia Belsito, Camilla Longobucco, Manuela Curcio, Catia Morelli, Luigi Pasqua & Antonella Leggio. (2023) Peptides Targeting HER2-Positive Breast Cancer Cells and Applications in Tumor Imaging and Delivery of Chemotherapeutics. Nanomaterials 13:17, pages 2476.
Crossref
Gehane Ghaly, Hatem Tallima, Eslam Dabbish, Norhan Badr ElDin, Mohamed K. Abd El-Rahman, Mahmoud A. A. Ibrahim & Tamer Shoeib. (2023) Anti-Cancer Peptides: Status and Future Prospects. Molecules 28:3, pages 1148.
Crossref
Peiman Norouzi, Maryam Mirmohammadi & Mohammad Hassan Houshdar Tehrani. (2022) Anticancer peptides mechanisms, simple and complex. Chemico-Biological Interactions 368, pages 110194.
Crossref
Noha Anwer Bayoumi & Mohamed Taha El-Kolaly. (2021) Utilization of nanotechnology in targeted radionuclide cancer therapy: monotherapy, combined therapy and radiosensitization. Radiochimica Acta 109:6, pages 459-475.
Crossref
Stefania De Luca, Valentina Verdoliva & Michele Saviano. (2020) Peptide Ligands Specifically Targeting HER2 Receptor and the Role Played by a Synthetic Model System of the Receptor Extracellular Domain: Hypothesized Future Perspectives. Journal of Medicinal Chemistry 63:24, pages 15333-15343.
Crossref
Nazanin Pirooznia, Khosrou Abdi, Davood Beiki, Farshad Emami, Seyed Shahriar Arab, Omid Sabzevari & Samira Soltani-Gooshkhaneh. (2020) 177Lu-labeled cyclic RGD peptide as an imaging and targeted radionuclide therapeutic agent in non-small cell lung cancer: Biological evaluation and preclinical study. Bioorganic Chemistry 102, pages 104100.
Crossref
Nazanin Pirooznia, Khosrou Abdi, Davood Beiki, Farshad Emami, Seyed Shahriar Arab, Omid Sabzevari, Zahra Pakdin-Parizi & Parham Geramifar. (2020) Radiosynthesis, Biological Evaluation, and Preclinical Study of a 68 Ga-Labeled Cyclic RGD Peptide as an Early Diagnostic Agent for Overexpressed α v β 3 Integrin Receptors in Non-Small-Cell Lung Cancer . Contrast Media & Molecular Imaging 2020, pages 1-11.
Crossref
Ryan A. Davis, Sven H. Hausner & Julie L. Sutcliffe. 2019. Radiopharmaceutical Chemistry. Radiopharmaceutical Chemistry 137 162 .
Annibale Versari, Angelina Filice, Massimiliano Casali, Martina Sollini & Andrea Frasoldati. 2018. Clinical Applications of Nuclear Medicine Targeted Therapy. Clinical Applications of Nuclear Medicine Targeted Therapy 483 503 .
Isaac M. Jackson, Peter J.H. Scott & Stephen Thompson. (2017) Clinical Applications of Radiolabeled Peptides for PET. Seminars in Nuclear Medicine 47:5, pages 493-523.
Crossref
Jean-Philippe Bapst & Alex N. Eberle. (2017) Receptor-Mediated Melanoma Targeting with Radiolabeled α-Melanocyte-Stimulating Hormone: Relevance of the Net Charge of the Ligand. Frontiers in Endocrinology 8.
Crossref
Didier J. Colin, James A. H. Inkster, Stéphane Germain & Yann Seimbille. (2016) Preclinical validations of [18F]FPyPEGCBT-c(RGDfK): a 18F-labelled RGD peptide prepared by ligation of 2-cyanobenzothiazole and 1,2-aminothiol to image angiogenesis. EJNMMI Radiopharmacy and Chemistry 1:1.
Crossref
Dimitrios Psimadas & Eirini Fragogeorgi. 2016. Handbook of Small Animal Imaging. Handbook of Small Animal Imaging 385 406 .
Matthias C. Schmidt, Klara Uhrhan, Thomas Fischer, Stephan Schmitz, Birgid Markiefka, Alexander Drzezga & Dirk Stippel. (2015) Complete Remission of Metastatic Neuroendocrine Paragastric Carcinoma After “Neoadjuvant” Peptide Receptor Radionuclide Therapy and Surgery. Clinical Nuclear Medicine 40:8, pages 667-669.
Crossref
Jason T. Duskey & Kevin G. Rice. (2014) Nanoparticle Ligand Presentation for Targeting Solid Tumors. AAPS PharmSciTech 15:5, pages 1345-1354.
Crossref
Annibale VersariMartina SolliniAndrea FrasoldatiAlessandro FraternaliAngelina FiliceArmando FroioMattia AstiFederica FioroniNadia CremoniniDaniel PutzerPaola Anna Erba. (2014) Differentiated Thyroid Cancer: A New Perspective with Radiolabeled Somatostatin Analogues for Imaging and Treatment of Patients. Thyroid 24:4, pages 715-726.
Crossref
Susan Richter, Vincent Bouvet, Melinda Wuest, Ralf Bergmann, Joerg Steinbach, Jens Pietzsch, Ines Neundorf & Frank Wuest. (2012) 18F-Labeled phosphopeptide-cell-penetrating peptide dimers with enhanced cell uptake properties in human cancer cells. Nuclear Medicine and Biology 39:8, pages 1202-1212.
Crossref
Marija Mirković, Drina Janković, Sanja Vranješ‐Đurić, Magdalena Radović, Dragana Stanković, Dušan Mijin & Nadežda Nikolić. (2012) Novel tetradentate diamine dioxime ligands: synthesis, characterization and in vivo behavior of their 99m Tc‐complexes . Applied Organometallic Chemistry 26:7, pages 347-355.
Crossref
Fabio D. Nascimento, Lucie Sancey, Alexandre Pereira, Claire Rome, Vitor Oliveira, Eduardo B. Oliveira, Helena B. Nader, Tetsuo Yamane, Irina Kerkis, Ivarne L. S. Tersariol, Jean-Luc Coll & Mirian A. F. Hayashi. (2011) The Natural Cell-Penetrating Peptide Crotamine Targets Tumor Tissue in Vivo and Triggers a Lethal Calcium-Dependent Pathway in Cultured Cells . Molecular Pharmaceutics 9:2, pages 211-221.
Crossref
K. P. Koopmans & A. W. J. M. Glaudemans. (2012) Rationale for the use of radiolabelled peptides in diagnosis and therapy. European Journal of Nuclear Medicine and Molecular Imaging 39:S1, pages 4-10.
Crossref
M. Fani, S. Good & H. R. Maecke. 2011. Handbook of Nuclear Chemistry. Handbook of Nuclear Chemistry 2143 2178 .
Snigdha Praharaj, Douglas Overbey & Michael F Giblin. (2010) Radiometallated peptides targeting guanylate cyclase C and the urokinase-type plasminogen activator receptor. Future Oncology 6:8, pages 1325-1337.
Crossref
Alex N. Eberle, Jean-Philippe Bapst, Martine Calame, Heidi Tanner & Sylvie Froidevaux. 2010. Melanocortins: Multiple Actions and Therapeutic Potential. Melanocortins: Multiple Actions and Therapeutic Potential 133 142 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.